OncoMatch

OncoMatch/Clinical Trials/NCT03014687

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

Is NCT03014687 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole for antibiotics.

Phase 4RecruitingSt. Joseph's Hospital and Medical Center, PhoenixNCT03014687Data as of May 2026

Treatment: Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole — To find out whether oral antibiotics given after transsphenoidal endoscopic surgery for pituitary adenoma improves sinus and nasal symptoms, reduces the incidence of infection (sinusitis), and helps mucosal healing in the nasal passages.

Check if I qualify

Eligibility summary

For patients with pituitary adenoma.

This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.

US trial sites

  • Barrow Brain and Spine · Phoenix, Arizona

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify